|
BMS-908662
|
DB12854 |
[BMS-908662 has been used in trials studying the treatment of Melanoma and Colorectal Cancer.] |
|
Melengestrol
|
DB11529 |
[Melengestrol is a steroidal progestin and antineoplastic agent which was never marketed. An acylated derivative, melengestrol acetate, is used as a growth promoter in animals.] |
|
Pholcodine
|
DB09209 |
[Pholcodine formula is 3-o-morpholinoethylmorphine and it is classified as an antitussive which is defined as an opioid cough suppressant. It belongs to the opioid family of compounds and it is widely used.[A31738] Pholcodine activity is the suppression of unproductive cough and it also has a mild sedative effect with little or no analgesic effects.[A31742] Pholcodine is not prescribed in the United States where it is classed as a Schedule I drug. It is categorized as Class B drug in the UK and officially taken out of the shelves in 2008. Pholcodine is not approved in Canada.] |
|
Apricitabine
|
DB12855 |
[Apricitabine has been used in trials studying the treatment of HIV Infections.] |
|
Timonacic
|
DB12856 |
[Timonacic has been used in trials studying the treatment of HIV Infections.] |
|
NVP-LEQ-506
|
DB12857 |
[LEQ506 has been used in trials studying the treatment of Advanced Solid Tumors, Recurrent or Refractory Medulloblastoma, and Locally Advanced or Metastatic Basal Cell Carcinoma.] |
|
Etalocib
|
DB12850 |
[Etalocib has been used in trials studying the treatment of Pancreatic Cancer, Carcinoma, Non-Small-Cell Lung, and Unspecified Adult Solid Tumor, Protocol Specific.] |
|
Miravirsen
|
DB12851 |
[Miravirsen has been investigated for the treatment of Hepatitis C and Hepatitis C, Chronic.] |
|
MK-0752
|
DB12852 |
[Mk 0752 is under investigation in clinical trial NCT00572182 (MK0752 in Treating Young Patients With Recurrent or Refractory CNS Cancer).] |
|
DA-6886
|
DB12853 |
[DA-6886 has been used in trials studying the treatment of Irritable Bowel Syndrome.] |
|
Isoflupredone
|
DB11522 |
|
|
Imidocarb
|
DB11521 |
[Imidocarb is a urea derivative used in veterinary medicine as an antiprotozoal agent for the treatment of infection with Babesia and other parasites.] |
|
Hygromycin B
|
DB11520 |
[Hygromycin B is an aminoglycoside antibiotic produced by the bacterium Streptomyces hygroscopicus which kills bacteria, fungi and higher eukaryotic cells by inhibiting protein synthesis.] |
|
Emtricitabine
|
DB00879 |
[Emtricitabine is a nucleoside reverse transcriptase inhibitor (NRTI) indicated for the treatment of HIV infection in adults[L9019] or combined with [tenofovir alafenamide] for the prevention of HIV-1 infection in high risk adolescents and adults.[L9010] Emtricitabine is a cytidine analogue.[L9019] The drug works by inhibiting HIV reverse transcriptase, preventing transcription of HIV RNA to DNA.[L9019]
Emtricitabine was granted FDA approval on 2 July 2003.[L9019]] |
|
Eprosartan
|
DB00876 |
[Eprosartan is an angiotensin II receptor antagonist used to treat hypertension. It performs 2 actions on the renin angiotensin system. By preventing the binding of angiotensin II to AT1, vascular smooth muscle relaxes and vasodilation occurs. By inhibiting norepinephrine production, blood pressure is further reduced.] |
|
Flupentixol
|
DB00875 |
[Flupentixol is an antipsychotic neuroleptic drug. It is a thioxanthene, and therefore closely related to the phenothiazines. Its primary use is as a long acting injection given two or three weekly to people with schizophrenia who have a poor compliance with medication and suffer frequent relapses of illness. It is a D1 and D2 receptor antagonist. It is not approved in the United States.] |
|
Chlorhexidine
|
DB00878 |
[A disinfectant and topical anti-infective agent used also as mouthwash to prevent oral plaque.] |
|
Sirolimus
|
DB00877 |
[A macrolide compound obtained from Streptomyces hygroscopicus that acts by selectively blocking the transcriptional activation of cytokines thereby inhibiting cytokine production. It is bioactive only when bound to immunophilins. Sirolimus is a potent immunosuppressant and possesses both antifungal and antineoplastic properties.] |
|
Conivaptan
|
DB00872 |
[Conivaptan is a non-peptide inhibitor of antidiuretic hormone (vasopressin). It was approved in 2004 for hyponatremia (low blood sodium levels) caused by syndrome of inappropriate antidiuretic hormone (SIADH). Conivaptan inhibits both isotypes of the vasopressin receptor (V1a and V2).] |
|
Terbutaline
|
DB00871 |
[A selective beta-2 adrenergic agonist used as a bronchodilator and tocolytic.] |
